We're just setting up a generation of people to move through life, having their cardiovascular events earlier and more severe ...

GSK has reached a near-$1bn deal to acquire 35Pharma, a Canadian biotech that develops drugs for heart and lung diseases, as ...

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that affects how the brain develops ...

Dr. Sadiya Khan, Director, Center for Population Science and Aging, Northwestern Medicine, joins John Williams to talk about the public splash around weight loss medications and how they interact ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...

Nancy Guthrie’s health update has sparked medical concerns about abruptly stopping heart medications. Cardiologists warn that ...

(KODE/KSNF) — We’ve heard a lot about the weight loss possibilities for drugs like Ozempic, Mounjaro and Zepbound, but these ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

February is Heart Month, an ideal time to assess your risk of heart disease and take steps to improve your health. This is ...

The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes.

University of Texas Medical Branch launches new anti-aging study: Can weight loss medications slow biological aging?